Table 1.

Clinical characteristic of patients. It represents age, body mass index (BMI), total cholesterol levels, estrogen receptor (ER), and progesterone receptors (PR), as well as the HER-2 status in different groups.

Clinical parameters	Control (n = 20)	Ca (n = 20)	UtCa (n = 20)
Age interval	32–79	32–71	40–75
Mean age	56.5 ± 11.6	55.0 ± 9.7	54.4 ± 11.0
BMI	25.0 ± 1.93	27.27 ± 1.49	26.82 ± 5.03
Cholesterol levels	202.5 ± 1.90	238.9 ± 57.9	244.2 ± 44.5
Estrogen receptor status (ER)
Positive	—	+14	+17
Negative	—	−6	−3
Progesterone receptor status (PR)
Positive	—	+10	+11
Negative	—	−10	−9
HER-2 receptor status (HER2)∗
Positive	—	+2	+6
Negative	—	−16	−12

The results for ER, HER2, and REP are represented as positive and negative numbers for the expression of receptors by number of women, while other parameters are expressed as mean ± standard deviation. UtCa group: patients treated with chemotherapy +300 mg Uncaria tomentosa daily (n = 20); Ca group: patients received chemotherapy (n = 20); control group (n = 20).

^∗To HER-2 receiver only data were obtained from 18 patients.